Castleview Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-28
| Closed | -$6.49K | – | 582 |
|
|
2024
Q2 | $6.49K | Buy |
28
+5
| +22% | +$1.16K | ﹤0.01% | 592 |
|
|
2024
Q1 | $4.96K | Hold |
23
| – | – | ﹤0.01% | 635 |
|
|
2023
Q4 | $5.95K | Hold |
23
| – | – | ﹤0.01% | 562 |
|
|
2023
Q3 | $5.91K | Hold |
23
| – | – | 0.01% | 468 |
|
|
2023
Q2 | $6.55K | Hold |
23
| – | – | 0.01% | 478 |
|
|
2023
Q1 | $6.4K | Hold |
23
| – | – | 0.01% | 472 |
|
|
2022
Q4 | $6.37K | Hold |
23
| – | – | 0.01% | 423 |
|
|
2022
Q3 | $6K | Sell |
23
-2
| -8% | -$522 | 0.01% | 430 |
|
|
2022
Q2 | $15.2K | Buy |
25
+2
| +9% | +$1.22K | 0.01% | 414 |
|
|
2022
Q1 | $4K | Sell |
23
-21,089
| -100% | -$3.67M | ﹤0.01% | 584 |
|
|
2021
Q4 | $88 | Buy |
+21,112
| New | +$88 | ﹤0.01% | 822 |
|
|
2021
Q2 | $8K | Buy |
+23
| New | +$8K | ﹤0.01% | 733 |
|